Two important features of atherosclerotic plaque progression are the presence of large necrotic cores, which arise from macrophage (Mf) death, and inflammation. In addition, advanced lesional Mfs accumulate large amounts of free cholesterol (FC). Using cultured Mfs, we have shown that FC loading induces inflammatory cytokines and activation of p38 MARK and the unfolded protein response (UPR). This is followed by down-regulation of the anti-apoptotic protein Bcl-2, induction of UPR/p38-mediated apoptosis, and, in the absence of phagocytosis, secondary cellular necrosis. Importantly, markers of the UPR are associated with Mfs in advanced atherosclerotic lesions. In this context, we hypothesize that Mf apoptosis and inflammatory responses in advanced atherosclerotic lesions, coupled with defective phagocytic clearance of the apoptotic cells, promote progression to the vulnerable plaque. To test this hypothesis, we will explore the role of the MKK3-p38 MAP kinase pathway in cholesterol-induced Mf death in vitro and in vivo (Aim I);investigate the FC-induced inflammatory response and the consequences of phagocytic clearance of FC-loaded Mfs (Aim II);and determine the role of Bcl-2 in FC-induced Mf apoptosis and plaque vulnerability (Aim III).
Each Aim will consist of a series of mechanistic experiments using cultured Mfs and, to determine relevance to plaque morphology, in-vivo experiments using mice with targeted mutations in critical genes in the aforementioned pathways: macrophage p38;the apoptotic cell phagocytic receptor Mer;and macrophage Bcl-2. These studies will involve essential interactions with each of the other projects of the program as well as use of the Lesion Analysis Core and biostatistic and QPCR core functions. The ultimate goal is to elucidate how FC-induced apoptosis and inflammatory cytokine production in Mfs and phagocytic clearance of apoptotic cells affect those late lesional characteristics that eventually lead to atherothrombotic vascular occlusion. New insights in this area may suggest new therapeutic strategies to combat cardiovascular disease.
Showing the most recent 10 out of 124 publications
